Michael Laessig

Title: Michael Laessig: Innovator in Cancer Treatment

Introduction

Michael Laessig is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. His work focuses on improving the effectiveness of immunotherapy regimens for cancer patients.

Latest Patents

Michael Laessig holds a patent for "Neoantigens and uses thereof for treating cancer." This patent outlines systems and methods for determining the likely responsiveness of a human cancer subject to a checkpoint blockade immunotherapy regimen. The process involves obtaining sequencing reads from cancer samples, determining human leukocyte antigen types, and computing clone fitness scores based on neoantigens. This innovative approach aims to quantify the responsiveness of cancer subjects to specific treatment regimens.

Career Highlights

Throughout his career, Michael Laessig has worked with esteemed institutions, including the Icahn School of Medicine at Mount Sinai. His research has contributed to advancements in cancer immunotherapy, showcasing his commitment to improving patient outcomes through scientific innovation.

Collaborations

Michael has collaborated with notable colleagues such as Marta Luksza and Vinod P Balachandran. These partnerships have further enhanced his research efforts and contributed to the development of effective cancer treatment strategies.

Conclusion

Michael Laessig's work in the field of cancer treatment exemplifies the impact of innovative thinking and collaboration in medical research. His patented technologies hold promise for improving the lives of cancer patients through more effective immunotherapy options.